FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081547373> ?p ?o ?g. }

• W3081547373 endingPage "1682" @default.
• W3081547373 startingPage "1672" @default.
• W3081547373 abstract "This study sought to describe the risk of thromboembolism in nonanticoagulated atrial fibrillation patients with Evaluated Heartvalves, Rheumatic or Artificial (EHRA) Type 2 valvular heart disease (VHD) <65 or 65 to 74 years of age and with 0 or 1 non-sex comorbidity of the CHA 2 DS 2 -VASc score. A minor, but important, proportion of patients with atrial fibrillation and VHD beyond moderate-to-severe mitral stenosis and/or a mechanical prosthetic valve, so-called EHRA Type 2 VHD, have 0 or 1 coexisting non-sex comorbidities of the CHA 2 DS 2 -VASc score, and are therefore not strongly recommended oral anticoagulant therapy according to guidelines. Whether these patients are truly low risk of thromboembolism has not been investigated. This was a cohort study of 55,613 patients identified in nationwide Danish registries from 2000 to 2018, of which 1,907 patients had EHRA Type 2 VHD. Risk of thromboembolism after 1 and 5 years of follow-up were calculated. At 1 year after atrial fibrillation diagnosis, patients with EHRA Type 2 VHD had a risk of thromboembolism between 1.2% and 1.5%, according to age group (<65 or 65 to 74 years of age), and number of non-sex comorbidities of the CHA 2 DS 2 -VASc score (0 or 1). Interestingly, in patients with EHRA Type 2 VHD <65 years of age with 0 or 1 comorbidity, the risk was 1.5% (95% confidence interval: 0.7% to 2.8%) and 1.5% (95% confidence interval: 0.6% to 3.4%) at 1 year after the atrial fibrillation diagnosis. These observations suggest that in atrial fibrillation patients with EHRA Type 2 VHD, who are not currently recommended oral anticoagulant therapy according to guidelines, the risk of thromboembolism may exceed the level above which oral anticoagulation is considered beneficial." @default.
• W3081547373 created "2020-09-08" @default.
• W3081547373 creator A5024774668 @default.
• W3081547373 creator A5038405190 @default.
• W3081547373 creator A5049507490 @default.
• W3081547373 creator A5063647251 @default.
• W3081547373 creator A5077679173 @default.
• W3081547373 creator A5078667862 @default.
• W3081547373 date "2020-12-01" @default.
• W3081547373 modified "2023-09-29" @default.
• W3081547373 title "Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease" @default.
• W3081547373 cites W1751906644 @default.
• W3081547373 cites W1897329565 @default.
• W3081547373 cites W1973416160 @default.
• W3081547373 cites W1974375858 @default.
• W3081547373 cites W1974472268 @default.
• W3081547373 cites W1999468381 @default.
• W3081547373 cites W2028298306 @default.
• W3081547373 cites W2034606391 @default.
• W3081547373 cites W2073101005 @default.
• W3081547373 cites W2102420102 @default.
• W3081547373 cites W2102924526 @default.
• W3081547373 cites W2108360116 @default.
• W3081547373 cites W2112668676 @default.
• W3081547373 cites W2142749836 @default.
• W3081547373 cites W2155301214 @default.
• W3081547373 cites W2155397983 @default.
• W3081547373 cites W2158604698 @default.
• W3081547373 cites W2161951565 @default.
• W3081547373 cites W2515488477 @default.
• W3081547373 cites W2532949333 @default.
• W3081547373 cites W2540928320 @default.
• W3081547373 cites W2546446487 @default.
• W3081547373 cites W2551469077 @default.
• W3081547373 cites W2596816418 @default.
• W3081547373 cites W2740267370 @default.
• W3081547373 cites W2751630023 @default.
• W3081547373 cites W2774842899 @default.
• W3081547373 cites W2791443968 @default.
• W3081547373 cites W2792654461 @default.
• W3081547373 cites W2818661513 @default.
• W3081547373 cites W2912139642 @default.
• W3081547373 cites W2913217706 @default.
• W3081547373 cites W2946212138 @default.
• W3081547373 cites W2946773507 @default.
• W3081547373 cites W2971467356 @default.
• W3081547373 cites W3004050106 @default.
• W3081547373 cites W4211129082 @default.
• W3081547373 cites W905650230 @default.
• W3081547373 doi "https://doi.org/10.1016/j.jacep.2020.07.005" @default.
• W3081547373 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33334446" @default.
• W3081547373 hasPublicationYear "2020" @default.
• W3081547373 type Work @default.
• W3081547373 sameAs 3081547373 @default.
• W3081547373 citedByCount "1" @default.
• W3081547373 countsByYear W30815473732023 @default.
• W3081547373 crossrefType "journal-article" @default.
• W3081547373 hasAuthorship W3081547373A5024774668 @default.
• W3081547373 hasAuthorship W3081547373A5038405190 @default.
• W3081547373 hasAuthorship W3081547373A5049507490 @default.
• W3081547373 hasAuthorship W3081547373A5063647251 @default.
• W3081547373 hasAuthorship W3081547373A5077679173 @default.
• W3081547373 hasAuthorship W3081547373A5078667862 @default.
• W3081547373 hasBestOaLocation W30815473731 @default.
• W3081547373 hasConcept C126322002 @default.
• W3081547373 hasConcept C164705383 @default.
• W3081547373 hasConcept C2779134260 @default.
• W3081547373 hasConcept C2779161974 @default.
• W3081547373 hasConcept C2779736815 @default.
• W3081547373 hasConcept C71924100 @default.
• W3081547373 hasConceptScore W3081547373C126322002 @default.
• W3081547373 hasConceptScore W3081547373C164705383 @default.
• W3081547373 hasConceptScore W3081547373C2779134260 @default.
• W3081547373 hasConceptScore W3081547373C2779161974 @default.
• W3081547373 hasConceptScore W3081547373C2779736815 @default.
• W3081547373 hasConceptScore W3081547373C71924100 @default.
• W3081547373 hasFunder F4320307115 @default.
• W3081547373 hasFunder F4320307765 @default.
• W3081547373 hasFunder F4320307779 @default.
• W3081547373 hasFunder F4320307813 @default.
• W3081547373 hasFunder F4320310441 @default.
• W3081547373 hasFunder F4320310465 @default.
• W3081547373 hasFunder F4320321625 @default.
• W3081547373 hasFunder F4320323077 @default.
• W3081547373 hasFunder F4320324292 @default.
• W3081547373 hasFunder F4320337601 @default.
• W3081547373 hasIssue "13" @default.
• W3081547373 hasLocation W30815473731 @default.
• W3081547373 hasOpenAccess W3081547373 @default.
• W3081547373 hasPrimaryLocation W30815473731 @default.
• W3081547373 hasRelatedWork W1226468885 @default.
• W3081547373 hasRelatedWork W2034606391 @default.
• W3081547373 hasRelatedWork W2074833529 @default.
• W3081547373 hasRelatedWork W2127690875 @default.
• W3081547373 hasRelatedWork W2284869607 @default.
• W3081547373 hasRelatedWork W3025182829 @default.
• W3081547373 hasRelatedWork W3028901408 @default.
• W3081547373 hasRelatedWork W3099064439 @default.

• next